BIOMERICA INC Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
BIOMERICA INC (BMRA) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 352.85 thousand shares for the 3-month period ending 2014-02-28, per its 10-Q filed 2015-04-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2015-04-14
- BIOMERICA INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2014-02-28 was 352.85K shares.
- BIOMERICA INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2012-11-30 was 418.95K shares, a 706.35% increase year-over-year.
- BIOMERICA INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2012-08-31 was 350.80K shares, a 901.87% increase year-over-year.
- BIOMERICA INC incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2012-02-29 was 247.61K shares.
- BIOMERICA INC incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2013 was 426.69K shares, a 94.10% increase from fiscal 2012.
- BIOMERICA INC incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2012 was 219.83K shares, a 509.32% increase from fiscal 2011.
- BIOMERICA INC incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2011 was 36.08K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2014-02-28 | 352.85K shares 10-Q · filed 2015-04-14 | |||
| 2013-05-31 | 426.69K shares 10-K · filed 2014-08-29 | |||
| 2013-02-28 | 438.25K shares 10-Q · filed 2014-04-14 | |||
| 2012-11-30 | 418.95K shares 10-Q · filed 2014-01-14 | 322.98K shares 10-Q · filed 2014-01-14 | ||
| 2012-08-31 | 350.80K shares 10-Q · filed 2013-10-15 | |||
| 2012-05-31 | 219.83K shares 10-K · filed 2013-08-29 | |||
| 2012-02-29 | 247.61K shares 10-Q · filed 2013-04-15 | 174.93K shares 10-Q · filed 2013-04-15 | ||
| 2011-11-30 | 51.96K shares 10-Q · filed 2013-01-14 | 40.04K shares 10-Q · filed 2013-01-14 | ||
| 2011-08-31 | 35.01K shares 10-Q · filed 2012-10-12 | |||
| 2011-05-31 | 36.08K shares 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |